Anterior gradient protein 2 (AGR2) is an independent prognostic factor in ovarian high-grade serous carcinoma (Q44677297)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Anterior gradient protein 2 (AGR2) is an independent prognostic factor in ovarian high-grade serous carcinoma	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Anterior gradient protein 2 (AGR2) is an independent prognostic factor in ovarian high-grade serous carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Carsten Denkert

8

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

author name string

S Darb-Esfahani

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

F Fritzsche

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

G Kristiansen

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

W Weichert

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

J Sehouli

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

I Braicu

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

M Dietel

7

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

publication date

3 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Virchows Archiv

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

461

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

109-116

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

The biology of ovarian cancer: new opportunities for translation

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

Integrated genomic analyses of ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

First-line therapy in ovarian cancer trials.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

Progressive determination during formation of the anteroposterior axis in Xenopus laevis.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

Anterior gradient 2: A novel player in tumor cell biology

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

Prognostic relevance of AGR2 expression in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

Differential expression of anterior gradient gene AGR2 in prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

Anterior gradient-2 is overexpressed by fibrolamellar carcinomas

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

Evaluation of a hormone receptor-positive ovarian carcinoma subtype with a favourable prognosis by determination of progesterone receptor and oestrogen receptor 1 mRNA expression in formalin-fixed paraffin-embedded tissue.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

My approach to and thoughts on the typing of ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

Evaluation of midkine and anterior gradient 2 in a multimarker panel for the detection of ovarian cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

Physiological stress induces the metastasis marker AGR2 in breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

Hypoxia--a key regulatory factor in tumour growth

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

21 January 2018

Increased plasma concentrations of anterior gradient 2 protein are positively associated with ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22752467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of AGR2 in non small cell lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22752467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance

1 reference

https://pubmed.ncbi.nlm.nih.gov/22752467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00428-012-1273-4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44677297&oldid=2206839045"